A detailed history of Accent Capital Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Accent Capital Management, LLC holds 368 shares of NVO stock, worth $49,978. This represents 0.03% of its overall portfolio holdings.

Number of Shares
368
Previous 174 111.49%
Holding current value
$49,978
Previous $22.5 Million 133.43%
% of portfolio
0.03%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$122.71 - $146.91 $23,805 - $28,500
194 Added 111.49%
368 $52.5 Million
Q4 2023

Mar 19, 2024

BUY
$87.78 - $105.45 $15,273 - $18,348
174 New
174 $18 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $307B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Accent Capital Management, LLC Portfolio

Follow Accent Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accent Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Accent Capital Management, LLC with notifications on news.